Explore 3 Stock Ideas & Industry Insights Download Free Report

Nova Leap Health Corp

Healthcare CA NLH

0.37CAD
0.01(2.78%)

Last update at 2026-06-19T17:54:00Z

Day Range

0.370.37
LowHigh

52 Week Range

0.220.39
LowHigh

Fundamentals

  • Previous Close 0.36
  • Market Cap34.05M
  • Volume12000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA1.59M
  • Revenue TTM31.47M
  • Revenue Per Share TTM0.36
  • Gross Profit TTM 12.48M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.13205M 1.81M -1.36599M -1.20656M 2.47M
Minority interest - - - - -
Net income -0.18986M 1.38M -1.05468M -0.83574M 1.76M
Selling general administrative 10.55M 8.44M 8.42M 9.68M 7.58M
Selling and marketing expenses - - - - -
Gross profit 12.48M 9.89M 9.77M 9.98M 7.21M
Reconciled depreciation 0.83M 0.58M 0.89M 1.36M 0.86M
Ebit - - - -1.06211M -1.23138M
Ebitda - - - 0.42M 3.74M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 1.11M 0.86M 0.46M -1.06211M 3.89M
Other operating expenses - - - - -
Interest expense 0.35M 0.11M 0.14M 0.27M 0.40M
Tax provision 0.06M 0.43M -0.31131M -0.37082M 0.71M
Interest income - - - - -
Net interest income -0.34987M -0.10686M -0.14475M -0.27099M -0.40112M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - -0.37082M 0.71M
Total revenue 31.47M 25.76M 26.18M 28.21M 21.28M
Total operating expenses 30.36M 24.90M 25.72M 29.27M 17.39M
Cost of revenue 18.98M 15.87M 16.41M 18.23M 14.07M
Total other income expense net -0.88818M 1.06M -1.68140M 0.13M -1.01945M
Discontinued operations - - - - -
Net income from continuing ops -0.18986M 1.38M -1.05468M -0.83574M 1.76M
Net income applicable to common shares - - - -0.83574M 1.76M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 23.48M 22.39M 20.90M 23.95M 26.77M
Intangible assets 0.55M 0.63M 0.54M 1.09M 2.08M
Earning assets - - - - -
Other current assets - - - - -
Total liab 4.44M 4.14M 2.70M 5.27M 8.29M
Total stockholder equity 19.04M 18.25M 18.20M 18.68M 18.48M
Deferred long term liab - - - - -
Other current liab - - - 0.06M 0.43M
Common stock - - - 18.96M 17.14M
Capital stock 19.10M 19.10M 18.96M 18.96M 17.14M
Retained earnings -1.05886M -0.86899M -2.24746M -1.19278M -0.35704M
Other liab - - - - 0.14M
Good will 17.06M 15.97M 14.62M 16.04M 16.71M
Other assets - - - 1.35M 0.73M
Cash 1.49M 1.40M 0.89M 1.27M 1.73M
Cash and equivalents - - - - -
Total current liabilities 3.73M 3.24M 1.78M 3.99M 6.23M
Current deferred revenue - - - - -
Net debt 0.51M 0.14M - 1.20M 3.15M
Short term debt - - - - -
Short long term debt 1.91M 1.32M 0.21M 2.36M 3.99M
Short long term debt total - - - - -
Other stockholder equity - - - -1.21546M -0.08062M
Property plant equipment - - - 1.49M 1.29M
Total current assets 3.59M 3.42M 2.84M 3.98M 5.96M
Long term investments - - - - -
Net tangible assets - - - 1.55M -0.30411M
Short term investments - - - - -
Net receivables 1.84M 1.70M 1.65M 2.41M 3.94M
Long term debt 0.09M 0.22M - 0.12M 0.90M
Inventory - - - - -
Accounts payable 1.47M 1.56M 1.24M 1.23M 1.31M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 19.89M 18.97M 18.05M 19.97M 20.81M
Capital lease obligations 0.92M 0.98M 1.19M 1.49M 1.32M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -1.59100M -0.02313M -0.05624M -7.40173M
Change to liabilities - - - -0.06714M 0.36M
Total cashflows from investing activities - - - -0.05624M -7.40173M
Net borrowings -0.08542M 0.66M -2.46025M -2.92163M 0.19M
Total cash from financing activities -0.25107M 0.73M -2.51607M -1.41358M 4.33M
Change to operating activities - - - -0.26069M -0.39644M
Net income -0.18986M 1.38M -1.05468M -0.83574M 1.76M
Change in cash 0.09M 0.51M -0.37788M -0.46080M -1.04540M
Begin period cash flow 1.40M 0.89M 1.27M 1.73M 2.78M
End period cash flow 1.49M 1.40M 0.89M 1.27M 1.73M
Total cash from operating activities 1.56M 1.39M 2.15M 1.02M 2.18M
Issuance of capital stock - - 0.00000M 1.79M 4.38M
Depreciation 0.83M 0.58M 0.89M 1.36M 0.86M
Other cashflows from investing activities - - - - -
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory - - - - -
Change to account receivables -0.13909M -0.04579M 0.10M 0.42M -0.76307M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - -0.32964M -0.41968M
Change to netincome - - - 0.61M 0.15M
Capital expenditures 0.00000M 0.03M 0.03M 0.07M 0.07M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.18707M 0.24M 0.10M -0.11042M -0.59627M
Stock based compensation 0.11M 0.11M 0.13M 0.36M 0.37M
Other non cash items 0.33M 0.06M 0.17M 0.24M 0.37M
Free cash flow 1.56M 1.36M 2.13M 0.95M 2.18M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NLH
Nova Leap Health Corp
0.01 2.78% 0.37 - 20.49 1.08 1.30 0.83 24.88
NPTH
NeuPath Health Inc
-0.01 1.67% 0.59 - 7.75 0.39 1.69 0.50 13.93
KDA
KDA Group Inc
-0.005 6.25% 0.07 - - 72.57 2.93 85.92 23.03
PHA
Premier Health of America Inc
- -% 0.01 - 35.97 0.01 1.19 0.52 71.65
JNH
Jack Nathan Medical Corp
- -% 0.01 - - 0.25 7.84 0.64 -1.921

Reports Covered

Stock Research & News

Profile

Nova Leap Health Corp., together with its subsidiaries, provides home-based and community-based healthcare services in the United States and Canada. It offers home and home health care services, including dementia care, companionship, personal and skilled nursing care, respite care, palliative care, care management, cooking and meal preparation, light housekeeping, daily living activities, transportation, medication reminders, and medication administration by nursing staff. The company provides its services through private homes, assisted living communities, hospitals, nursing homes, hospice, and rehabilitation centers. Nova Leap Health Corp. was incorporated in 2015 and is headquartered in Halifax, Canada.

Nova Leap Health Corp

7071 Bayers Road, Halifax, NS, Canada, B3L 2C2

Key Executives

Name Title Year Born
Mr. Christopher Donald Dobbin C.A., CPA, CA, CPA CEO, Pres & Director 1975
Ms. Megan Spidle CPA, C.A. CFO & Corp. Sec. 1977
Ms. Alison DeBlois VP of Operations (U.S.) NA
Mr. Michael Gremley Mang. of Corp. Devel. NA
Mr. Christopher Donald Dobbin C.A., CPA, CA, CPA CEO, President & Director 1975
Mr. Chris LeBlanc Company Secretary & CFO NA
Ms. Melissa Anderson Vice President of Operations (U.S.) NA
Mr. Christopher Donald Dobbin C.A., CPA CEO, President & Director 1975
Ms. Melissa Anderson Senior President of Operations (U.S.) NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.